Direct Access Physiotherapy in the Pediatric Emergency Department

Musculoskeletal Pain Clinical Trial

— PedEDmsk  

Official title:

Improving Access to Quality Care for Children and Adolescents Presenting to the Pediatric Emergency Department With Musculoskeletal Problems: a Pilot Randomized Control Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06069011
• Other study ID #: 2024-9673
• Status: Completed
• Phase: N/A
• Start date: September 18, 2023
• Est. completion date: December 31, 2023

Study information

• Verified date: April 2024
• Source: McGill University Health Centre/Research Institute of the McGill University Health Centre
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare two methods of managing low acuity musculoskeletal complaints in children and adolescents ages 6 to 17.99 years in the pediatric emergency department. The main question it aims to answer is whether delivering care in two methods is feasible. Participants will receive care while in the emergency department and will be followed for a period of 1-month post-presentation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 66
• Est. completion date: December 31, 2023
• Est. primary completion date: December 31, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 6 Years to 17 Years

Eligibility

Inclusion Criteria:

• aged 6.00-17.99 years of age
• present to the Montreal Children's Hospital Emergency Department with a suspected MSK complaint, traumatic or not
• are given a triage score of 3 (urgent), 4 (less urgent), or 5 (nonurgent) according to the Canadian Triage and Acuity Scale (CTAS)
• are able to communicate in French or English

Exclusion Criteria:

• present with a major MSK condition requiring urgent care (e.g., open fracture, open wound)
• a red flag (e.g. progressive neurological disorder, infectious symptoms)
• a co-morbid unstable condition.

Related Conditions & MeSH terms

• Emergencies
• Musculoskeletal Diseases
• Musculoskeletal Diseases or Conditions
• Musculoskeletal Pain

Intervention

Other:
• Interdisciplinary management
assessment and treatment in an interdisciplinary model
• usual care
assessment and treatment in usual care model

Locations

Country	Name	City	State
Canada	McGill University Health Center	Montréal	Quebec

Sponsors (1)

Lead Sponsor	Collaborator
McGill University Health Centre/Research Institute of the McGill University Health Centre

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of consent	rate of consented patients related to patients approached rate of randomization, feasibility of administration of outcomes	through study completion an average of 4 weeks post-enrolment
Primary	Completed outcome measures	proportion of participants who complete all outcome measures	through study completion an average of 4 weeks post-enrolment
Secondary	Pain intensity on faces rating scale	Pain intensity on faces rating scale, scale from 0 to 10, with 10 being a worse score	through study completion an average of 4 weeks post-enrolment
Secondary	Pain interference with function PROMIS scale	PROMIS Pediatric Pain Interference - Short Form 8a, 8 items scores from 1-5 with 5 being a worse outcome	through study completion an average of 4 weeks post-enrolment